Majka M - Search Results

1

Myogenic Differentiation of iPS Cells Shows Different Efficiency in Simultaneous Comparison of Protocols.

Ulman A, Kot M, Skrzypek K, Szewczyk B, Majka M. Ulman A, et al. Among authors: majka m. Cells. 2021 Jul 2;10(7):1671. doi: 10.3390/cells10071671. Cells. 2021. PMID: 34359837 Free PMC article.

2

Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, Jozkowicz A. Kozakowska M, et al. Among authors: majka m. Antioxid Redox Signal. 2012 Jan 15;16(2):113-27. doi: 10.1089/ars.2011.3964. Epub 2011 Oct 19. Antioxid Redox Signal. 2012. PMID: 21827279 Free PMC article.

3

Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.

Skrzypek K, Kusienicka A, Szewczyk B, Adamus T, Lukasiewicz E, Miekus K, Majka M. Skrzypek K, et al. Among authors: majka m. Oncotarget. 2015 Oct 13;6(31):31378-98. doi: 10.18632/oncotarget.5145. Oncotarget. 2015. PMID: 26384300 Free PMC article.

4

Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress.

Szewczyk B, Skrzypek K, Majka M. Szewczyk B, et al. Among authors: majka m. Curr Drug Targets. 2017;18(1):98-107. doi: 10.2174/1389450117666151209124123. Curr Drug Targets. 2017. PMID: 26674534 Review.

5

Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications.

Majka M, Sułkowski M, Badyra B, Musiałek P. Majka M, et al. Stem Cells Transl Med. 2017 Oct;6(10):1859-1867. doi: 10.1002/sctm.16-0484. Epub 2017 Aug 24. Stem Cells Transl Med. 2017. PMID: 28836732 Free PMC article. Review.

6

SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.

Skrzypek K, Kusienicka A, Trzyna E, Szewczyk B, Ulman A, Konieczny P, Adamus T, Badyra B, Kortylewski M, Majka M. Skrzypek K, et al. Among authors: majka m. Cell Death Dis. 2018 May 29;9(6):643. doi: 10.1038/s41419-018-0693-8. Cell Death Dis. 2018. PMID: 29844345 Free PMC article.

7

C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas.

Marona P, Górka J, Kotlinowski J, Majka M, Jura J, Miekus K. Marona P, et al. Among authors: majka m. Cells. 2019 Mar 22;8(3):272. doi: 10.3390/cells8030272. Cells. 2019. PMID: 30909397 Free PMC article. Review.

8

Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.

Musiał-Wysocka A, Kot M, Sułkowski M, Badyra B, Majka M. Musiał-Wysocka A, et al. Among authors: majka m. Int J Mol Sci. 2019 Apr 12;20(8):1807. doi: 10.3390/ijms20081807. Int J Mol Sci. 2019. PMID: 31013696 Free PMC article.

9

The Pros and Cons of Mesenchymal Stem Cell-Based Therapies.

Musiał-Wysocka A, Kot M, Majka M. Musiał-Wysocka A, et al. Among authors: majka m. Cell Transplant. 2019 Jul;28(7):801-812. doi: 10.1177/0963689719837897. Epub 2019 Apr 24. Cell Transplant. 2019. PMID: 31018669 Free PMC article. Review.

10

AFM-based Analysis of Wharton's Jelly Mesenchymal Stem Cells.

Szydlak R, Majka M, Lekka M, Kot M, Laidler P. Szydlak R, et al. Among authors: majka m. Int J Mol Sci. 2019 Sep 5;20(18):4351. doi: 10.3390/ijms20184351. Int J Mol Sci. 2019. PMID: 31491893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page